The association of artificial intelligence-enabled coronary plaque analysis with future non-ST elevation myocardial infarction

人工智能辅助冠状动脉斑块分析与未来非ST段抬高型心肌梗死的关联

阅读:1

Abstract

BACKGROUND: There is emerging evidence that plaque features may play a critical role in future acute coronary syndrome. In this study, we analyzed plaque features using an artificial intelligence-enabled algorithm in a clinical cohort who developed non-ST-elevation myocardial infarction (NSTEMI) following coronary CT angiogram (CCTA). METHODS: We performed a case-control study selected from 13 751 consecutive cases in a single center referred for outpatient CCTA. After a follow-up of 4.3 ± 4 years, 48 patients without preexisting coronary disease developed NSTEMI. Controls (N = 187) were matched to the cases on age, gender, BMI, and kilovoltage for CTA acquisition. Quantitative plaque analysis was performed using artificial intelligence-enabled Autoplaque software (Autoplaque version 3.0; Cedars-Sinai Medical Center, Los Angeles, California, USA). Multivariable Cox proportional hazards models were performed to identify the predictors of NSTEMI. RESULTS: The mean age was 64 ± 11 years. Both case and control groups had mild stenosis at baseline (26 vs 17%, P = 0.01). The total calcified plaque and fibrous plaque volume were not different (P = 0.10 and P = 0.13, respectively). Necrotic core plaque volume and fibrous fatty plaque volume were higher in the NSTEMI group (28 ± 29 vs 9 ± 13 mm3, 169 ± 157 vs 84 ± 105 mm3, respectively, both P < 0.01). In multivariable Cox regression, necrotic core volume portended the greatest risk of NSTEMI, a seven-fold higher than that of total plaque volume. CONCLUSION: Using artificial intelligence-enabled plaque analysis, noncalcified plaque volume, especially necrotic core and fibrous fatty plaque volume are important precursors for future NSTEMI events.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。